Despite recent therapeutic advances, many patients with myasthenia gravis (MG) still experience diagnostic delay, limited symptom control, and a reduced quality of life (QoL). Clinicians report uncertainty recognizing heterogeneous MG presentations and integrating new options such as neonatal Fc receptor (FcRn) antagonists into individualized care. Compounding this are ongoing challenges in recognizing variable MG presentations, aligning treatment goals through shared decision-making (SDM), and inconsistent assessment of psychiatric comorbidities and patient-reported outcomes. Education that integrates real patient experiences and current evidence is needed to help clinicians improve diagnostic accuracy, optimize therapy selection, and deliver more compassionate, collaborative, and outcomes-driven care. In this EfficientCME recorded webcast, expert faculty will guide learners to recognize and evaluate varying phenotypes of MG for early and accurate diagnosis, evaluate the mechanisms of action and latest data for emerging agents such as FcRn antagonists and communicate this with patients to create individualized MG treatments that consider adverse effects and QoL considerations to improve overall patient wellbeing.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 201 King of Prussia Rd.
Pricing
CME included with membership
| Integrative Psychiatry Certificate Program | $3,350 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Hospice & Palliative Medicine
- Medical Oncology
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Primary Care Sports Medicine
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.75 credits
- Commercial Support
-
ReleasedDec 16, 2025
-
Last day to claim creditDec 17, 2026 2 months left
-
PVI, PeerView Institute for Medical Education Redefining Treatment Pathways in Generalized Myasthenia Gravis: Strengthening Clinician Expertise in Diagnosis and Personalized Care With FcRn Antagonists
-
PRIME Education, Inc. (PRIME®) Quick Case Challenge: Implementing FcRn Antagonists in gMG Practice
-
eMedEd Modern Strategies in Generalized Myasthenia Gravis: Diagnosis, Therapy, and Individualized Care
